Some reports suggest that serum ALT to aspartate aminotransferase (AST) ratio (ALT/AST) is the most relevant predictor of fatty liver [11], insulin resistance [12] and metabolic syndrome [13, 14]. This evidence concerns the gene GPT and Insulin resistance.